SEC Stock Data Quick Answer Zymeworks Inc. reported Operating Income of -$92.55 million for fiscal year 2025. Zymeworks Inc. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$92.55M +32.5% 2024 -$137.11M +0.7% 2023 -$138.05M -205.8% 2022 $130.53M +160.5% 2021 -$215.63M -15.0% 2020 -$187.47M — Quarterly Operating Income Quarter Ending Operating Income YoY QoQ September … Read more
Quick Answer Zymeworks Inc. reported R&D Expense of $143.62 million for fiscal year 2023. Zymeworks Inc. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2023 $143.62M -31.1% 2022 $208.60M +4.4% 2021 $199.75M +16.7% 2020 $171.20M — Quarterly R&D Expense Quarter Ending R&D Expense YoY QoQ March 31, 2024 $32.04M -30.2% -2.2% September … Read more
Quick Answer Zymeworks Inc. reported Stockholders Equity of $268.50 million for fiscal year 2025. Zymeworks Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $268.50M -20.7% 2024 $338.77M -27.1% 2023 $464.81M -5.7% 2022 $492.96M +97.9% 2021 $249.09M -39.2% 2020 $409.92M +66.9% 2019 $245.68M — Quarterly Stockholders Equity Quarter Ending Stockholders Equity … Read more
Quick Answer Zymeworks Inc. reported Cash and Equivalents of $41.16 million for fiscal year 2025. Zymeworks Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $41.16M -37.7% 2024 $66.10M -58.0% 2023 $157.56M -60.7% 2022 $400.91M +98.6% 2021 $201.87M — Quarterly Cash and Equivalents Quarter Ending Cash and Equivalents YoY … Read more
Quick Answer Zymeworks Inc. reported Total Assets of $346.53 million for fiscal year 2025. Zymeworks Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $346.53M -25.2% 2024 $463.09M -20.3% 2023 $580.88M -10.5% 2022 $648.73M +66.7% 2021 $389.13M — Quarterly Total Assets Quarter Ending Total Assets YoY QoQ September 30, 2025 $397.27M … Read more
Quick Answer Zymeworks Inc. reported Diluted EPS of $1.08 per share (loss) for fiscal year 2025. Zymeworks Inc. Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$1.08 +33.3% 2024 -$1.62 +5.8% 2023 -$1.72 -190.5% 2022 $1.90 +141.2% 2021 -$4.61 -28.8% 2020 -$3.58 — Quarterly Diluted EPS Quarter Ending Diluted EPS YoY … Read more
Quick Answer Zymeworks Inc. reported Net Income of -$81.13 million for fiscal year 2025. Zymeworks Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$81.13M +33.9% 2024 -$122.69M -3.4% 2023 -$118.67M -195.4% 2022 $124.34M +158.7% 2021 -$211.84M -17.3% 2020 -$180.55M — Quarterly Net Income Quarter Ending Net Income YoY QoQ September … Read more
Quick Answer Zymeworks Inc. reported Revenue (ASC 606) of $105.97 million for fiscal year 2025. Zymeworks Inc. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $105.97M +38.9% 2024 $76.30M +0.4% 2023 $76.01M -81.6% 2022 $412.48M +1446.0% 2021 $26.68M -31.5% 2020 $38.95M — Quarterly Revenue (ASC 606) Quarter Ending Revenue … Read more
Quick Answer Zymeworks Inc. reported Total Revenue of $105.97 million for fiscal year 2025. Zymeworks Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $105.97M +38.9% 2024 $76.30M +0.4% 2023 $76.01M -81.6% 2022 $412.48M +1446.0% 2021 $26.68M -31.5% 2020 $38.95M — Quarterly Total Revenue Quarter Ending Total Revenue YoY QoQ September … Read more
Quick Answer Zymeworks Inc. reported Total Revenue of $105.97 million for fiscal year 2025. Zymeworks Inc. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $105.97M+38.9% $76.30M+0.4% $76.01M-81.6% $412.48M+1446.0% $26.68M-31.5% $38.95M Revenue (ASC 606) $105.97M+38.9% $76.30M+0.4% $76.01M-81.6% $412.48M+1446.0% $26.68M-31.5% $38.95M Net Income -$81.13M+33.9% -$122.69M-3.4% -$118.67M-195.4% $124.34M+158.7% -$211.84M-17.3% -$180.55M Diluted EPS … Read more